US Patent Issued to Elanco US, Ambrx on April 29 for "Porcine G-CSF variants and their uses" (California, Indiana Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,462, issued on April 29, was assigned to Elanco US Inc. (Greenfield, Ind.) and Ambrx Inc. (La Jolla, Calif.).

"Porcine G-CSF variants and their uses" was invented by Peter Connor Canning (Noblesville, Ind.), Nickolas Knudsen (Escondido, Calif.) and Md Harunur Rashid (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed."

The patent was filed on Jan. 30, 2023, under Application No. 18/102,933.

*...